不同剂量去甲氧柔红霉素联合阿糖胞苷诱导治疗年轻初发急性髓系白血病的疗效和安全性分析

OBJECTIVE: To compare the efficacy, safety and long-term prognosis between different dose idarubicin (IDA) combined with cytarabine (IA) as induction chemotherapy in newly diagnosed young patients of acute myeloid leukemia (AML). METHODS: A total of 149 newly diagnosed young AML patients (APL exclud...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348532/
https://www.ncbi.nlm.nih.gov/pubmed/27587250
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348532/
https://www.ncbi.nlm.nih.gov/pubmed/27587250
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.08.010

Ejemplares similares